Vaxcyte, Inc. is a clinical-stage vaccine innovation company specializing in engineering high-fidelity vaccines to protect against bacterial infectious diseases. Its core products include broad-spectrum pneumococcal conjugate vaccines (PCVs…
HQ: San Carlos, CA, United States of Americavaxcyte.com
USD63.37-2.04%vs prev. close
Performance
1W
+4.47%
1M
-3.16%
3M
+9.90%
1Y
+40.33%
YTD
+40.20%
Valuation
P/E
—
EPS TTM
-8.05
Dividend yield
—
Size and risk
Market cap
$10.2B
Beta
1.29
Price history
PCVX price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Vaxcyte
PCVX
Biotechnology
Mkt cap (USD bn)
10.2
P/E
—
Div yld
—
1W
+4.5%
1M
-3.2%
3M
+9.9%
6M
+20.9%
1Y
+40.3%
YTD
+40.2%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Vaxcyte
PCVX
Biotechnology
10.2
—
—
+4.5%
-3.2%
+9.9%
+20.9%
+40.3%
+40.2%
Subscribe to Equity Analytics to compare PCVX with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.